Carl Zeiss Licences Digital Pathology from Olympus

17-Jul-2012

Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”

“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”

The companies are not making specific terms and conditions of the agreement public.

Facts, background information, dossiers
  • Carl Zeiss
  • Olympus
  • pathology
More about Carl Zeiss
  • News

    ZEISS acquires majority stake in Italian x-ray provider

    ZEISS (Germany) and BOSELLO HIGH TECHNOLOGY (BOSELLO) (Italy) have announced that the ZEISS Group will acquire a majority stake in the provider of industrial X-ray solutions.For ZEISS, BOSELLO’s tailor-made solutions are a further step in the process of evolving into a one-stop provider of ... more

    Record Revenue at ZEISS

    In the past 2016/17 fiscal year (ended 30 September 2017), ZEISS increased both its revenue and earnings to a record level: revenue rose by 10 percent to EUR 5.348 billion (prior year: EUR 4.881 billion). At EUR 770 million, earnings before interest and tax (EBIT) were significantly above t ... more

    ZEISS Group expands executive board

    The Supervisory Board of Carl Zeiss AG has decided to expand the Executive Board of the ZEISS Group, which currently has four members. This is in line with the implementation of the ZEISS portfolio strategy and anchors the business responsibility in the Executive Board. Effective 1 January ... more

More about Olympus
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE